RESPONd: remote symptom monitoring and management for cancer patients between ambulatory visits

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

RESPONd implements digitally enabled remote symptom monitoring across six tertiary, regional, and community cancer clinics using a stepped-wedge rollout over 1.5 years. Enrolled adults complete electronic patient-reported outcome (PRO) questionnaires at home (weekly on active treatment or monthly on follow-up), and study nurses monitor responses and contact patients to provide tailored support. Collected PRO data are used in weekly clinic triage huddles to guide care and improve coordination. The study measures patient outcomes, healthcare use (including emergency visits), and clinic workflow efficiencies while collecting participant experience feedback.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18
* Have cancer
* Receiving care in one of the participating clinics.
* Able to sign up for MyAHS Connect and consent.
* Have access to a digital device at home
* Able to complete their electronic PROs questionnaire without support from the clinic team on a weekly (patients on active treatment) or monthly (patients on follow-up) basis, for the duration of the intervention or until they are discharged from the clinic.
* Regular access to a telephone in order for the study nurse to call patients to provide symptom management support.

Exclusion Criteria:

* Patients with cognitive disabilities or who cannot reliably report symptoms independently.
* Patients not residing in Alberta, as government-issued ID is required to register for MyAHS Connect.
* Patients who do not have regular access to a telephone, as the study nurse needs to be able to call patients to provide symptom management support.
* Patients who do not speak English, or who do not have an English-speaking friend, family member, or caregiver to assist them, as the electronic PROs questionnaire is only available in English at this time.

Where it's running

• Arthur J. E. Child Comprehensive Cancer Centre
  Calgary, Alberta, Canada Recruiting
• Cross Cancer Institute
  Edmonton, Alberta, Canada Recruiting
• Central Alberta Cancer Centre
  Red Deer, Alberta, Canada Recruiting
• High River Community Cancer Centre
  High River, Alberta, Canada Not yet recruiting

Study contacts

• Principal investigator: Linda Watson, RN, PhD — Cancer Care Alberta, Alberta Health Services
• Study coordinator: Chizoba Anyimukwu, MPH, DrPH
• Email: chizoba.anyimukwu@albertahealthservices.ca
• Phone: 587-943-3556

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Gyrotonic exercise for elders with breast cancer and Behcet disease

  We’re testing whether a gyrotonic exercise program helps older people who have both Behcet disease and breast cancer.

  Recruiting Cairo University · Giza, Dokki · NCT07929116

• PECS II vs SPSIP nerve blocks for pain after mastectomy

  This study tests whether two ultrasound-guided nerve blocks (PECS II and SPSIP) differ in how much opioid patients need after mastectomy.

  Recruiting Bursa City Hospital · Nilufer, Bursa · NCT07929090

• CG-7321: a first-in-human test in advanced solid tumors

  We’re testing CG-7321 alone and with fulvestrant to see if it’s safe and tolerable in adults with advanced solid tumors.

  Recruiting at 4 sites Phase 1 Chengdu Cynogen Bio-pharmaceutical Tech. Co., Ltd. · Fuzhou, Fujian and 3 other locations · NCT07923214

• Compare a new endoscopy-assisted breast-conserving surgery with the usual approach

  This study tests whether a new endoscopy-assisted breast-conserving technique can provide similar or better cosmetic outcomes and safety compared with conventional breast-conserving surgery in women with early breast cancer who want to preserve their breast.

  Recruiting Sir Run Run Shaw Hospital · Hangzhou, Zhejiang and 21 other locations · NCT07920094

• Different skin care approaches to prevent skin reactions after mastectomy radiation

  This study tests three standard skin care methods to see which best prevents radiation dermatitis in people who had a mastectomy and are receiving post-mastectomy radiation therapy.

  Recruiting at 7 sites Phase 2 Memorial Sloan Kettering Cancer Center · Basking Ridge, New Jersey and 6 other locations · NCT07918989

• 3D Heart Strain to Detect Early Cardiotoxicity in Cancer Therapy

  This study tests whether 3D echocardiography can detect early heart damage from cancer treatments like anthracyclines or HER2-targeted therapy better than standard 2D methods.

  Recruiting Region Skane · Lund, Skåne County · NCT07916337

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.